Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Title
Intervention Indication Therapeutic Area Year Actions
ECCS-50 (Cytori stem cell therapy) for moderate to severe hand dysfunction due to Scleroderma ECCS-50 (Adipose-derived stem and regenerative cells (ADRCs)) Hand dysfunction Dermatology , Musculoskeletal System 2017 View  |  Download
Entinostat for Hormone Refractory, HR+ Breast Cancer in Men and Postmenopausal Women Entinostat (SNDX-275; RG7746) Breast cancer Breast Cancer 2017 View  |  Download
Enzalutamide (Xtandi) for non-metastatic prostate cancer Enzalutamide (Xtandi; MDV3100) Prostate cancer Male Reproductive Cancer 2017 View  |  Download
Erdafitinib capsules for metastatic or surgically unresectable urothelial cancer with FGFR gene aberrations – second line therapy Erdafitinib (JNJ-42756493; BALVERSA) Urothelial cancer Urological Cancer 2017 View  |  Download
Esketamine for Treatment-resistant Depression Esketamine (JNJ-54135419; Keyzilen; AM-101; esketamine hydrochloride) Depression Mental and Behavioural Health 2017 View  |  Download
Fingolimod (Gilenya) oral formulation for multiple sclerosis in paediatric patients (aged 10 – 17 years) Fingolimod (Gilenya; FTY720; fingolimod hydrochloride) Multiple sclerosis (MS) Neurology 2017 View  |  Download
Fremanezumab for chronic and episodic migraine Fremanezumab (TEV-48125; Ajovy) Migraine Neurology 2017 View  |  Download
Galcanezumab for the prophylaxis of episodic and chronic migraine Galcanezumab (Emgality; LY-2951742) Migraine Neurology 2017 View  |  Download
Glasdegib for Acute Myeloid Leukaemia (AML) – first line Glasdegib (PF-04449913; glasdegib maleate) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2017 View  |  Download
Guadecitabine for Treatment of Naive Acute Myeloid Leukaemia Guadecitabine (SGI-110) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications